옵션
집 AI 프롬프트 목록 의료 건강 처방전 심사 보조

처방전 심사 보조

{:__('collect %s',처방전 심사 보조)}

AI를 활용하여 약사가 약물 상호작용, 용량 이상 및 금기 사항을 신속하게 식별하도록 지원하여 약물 안전성 및 심사 효율성을 향상시킵니다.

프롬프트 내용 복사 복사

Act as a senior clinical pharmacist and review the following patient prescription for compliance: The patient is a 65-year-old male diagnosed with Stage 2 hypertension and mild renal insufficiency (eGFR 45ml/min). The current prescription includes Amlodipine 5mg once daily, Hydrochlorothiazide 25mg once daily, and Ibuprofen 400mg three times daily for joint pain. Please analyze if there are potential drug-disease interactions, drug-drug interactions, or inappropriate dosing risks in this prescription, particularly regarding the use of NSAIDs in patients with renal insufficiency, and provide adjustment suggestions or warnings to ensure medication safety.

복사 복사

시니어 임상 약사로서 다음 환자의 처방전이 규정 준수 여부를 검토하십시오. 환자는 65세 남성으로 2기 고혈압 및 경도 신부전(eGFR 45ml/min) 진단을 받았습니다. 현재 처방에는 아밀로디핀 5mg 하루 1회, 하이드로클로로티아지드 25mg 하루 1회 및 관절통에 대한 이부프로펜 400mg 하루 3회가 포함됩니다. 이 처방에 특히 신부전 환자에서의 NSAIDs 사용과 관련된 잠재적인 약물-질병 상호작용, 약물-약물 상호작용 또는 부적절한 투여량 위험이 있는지 분석하고, 약물 안전성을 보장하기 위한 조정 제안 또는 경고를 제공하십시오.

복사 복사
의견 (0)
0/300

추천

처방전 심사 어시스턴트
Act as a senior clinical pharmacist. Review the provided patient electronic health record, including medical history, allergies, current medication list, and lab results, to audit the proposed prescription. Focus on analyzing drug-drug interaction risks, checking if dosages exceed renal adjustment limits, and identifying absolute contraindications. Finally, output a standardized audit report containing risk assessment levels and specific adjustment recommendations to ensure medication safety.
처방 검토 보조 도구
Act as a senior clinical pharmacist to review the provided patient prescription for compliance. First, extract patient demographics, diagnosis, and the list of prescribed medications. Then, based on the latest clinical practice guidelines and package inserts, evaluate the rationality of dosage, route of administration, and duration for each drug. Focus on identifying potential drug-drug interactions, drug-disease contraindications, or risks for special populations (e.g., hepatic or renal impairment). If potential issues are found, clearly specify the risk type and provide evidence-based alternative solutions or adjustment recommendations. Finally, output a structured, professional audit report to ensure patient safety and therapeutic efficacy.
처방전 감사 어시스턴트
Act as a senior clinical pharmacist to review the provided patient prescription for compliance. Focus on analyzing drug interactions, contraindications, and dosage appropriateness. Consider the patient's age, liver/kidney function, and allergy history to highlight potential risks and provide adjustment suggestions, ensuring the treatment plan aligns with the latest clinical guidelines.
처방전 감사 어시스턴트
Act as a senior clinical pharmacist to review the provided patient prescription for compliance. First, extract drug names, dosages, routes, and frequencies, cross-referencing them with the patient's age, renal/hepatic function, and allergy history. Second, check for drug interactions, contraindications, or off-label usage risks based on current clinical guidelines. Finally, if potential risks are identified, clearly specify the risk type and provide specific adjustment suggestions or alternative solutions, ensuring the output is concise, professional, and adheres to medical safety standards.
처방전 감사 어시스턴트
Act as a senior clinical pharmacist to review the provided patient prescription. First, extract patient demographics, diagnosis, and all drug names with dosages. Second, cross-reference these details against the latest clinical guidelines and package inserts to check for contraindications, drug-drug interactions, or dosage errors. Finally, if any safety risks are identified, clearly specify the risk and provide evidence-based adjustment suggestions or alternative therapies to support clinical decision-making.
처방전 검토 어시스턴트
Act as a senior clinical pharmacist and review the following patient prescription for compliance: The patient is a 65-year-old male diagnosed with Stage 2 hypertension and mild renal insufficiency (eGFR 45ml/min). Current medications include Amlodipine 5mg once daily, Hydrochlorothiazide 25mg once daily, and a newly prescribed Ibuprofen 400mg three times daily for joint pain. Analyze whether this prescription contains drug-disease contraindications, drug-drug interactions, or dosage adjustment needs, particularly regarding the risk of using non-steroidal anti-inflammatory drugs in patients with renal insufficiency, and provide specific adjustment suggestions or alternative solutions to ensure medication safety.
OR